Back to search

Article

Plasma Small Extracellular Vesicle-Derived GDF15 Predicts Resistance to PD-1/PD-L1-Based Therapy in Colorectal Cancer: A Pilot Study

2025-10-23

Abstract excerpt

<title>Abstract</title> <p>Background Immune checkpoint inhibitors (ICIs) have markedly improved cancer treatment outcomes, but both intrinsic and acquired resistance remain major barriers, particularly in microsatellite stable (MSS) colorectal cancer (CRC). Growth differentiation factor-15 (GDF15) contributes to tumor immune evasion, yet its clinical significance as a non-invasive liquid biopsy marker for predic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
716835bd-b714-56d4-a5fa-9bb7b3003162
DOI
10.21203/rs.3.rs-7732171/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasma Small Extracellular Vesicle-Derived GDF15 Predicts Resistance to PD-1/PD-L1-Based Therapy in Colorectal Cancer: A Pilot StudyDOI 10.21203/rs.3.rs-7732171/v1
Select a neighboring publication to make it the new centre.